ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock Earnings & Estimates
USA - NASDAQ:ARQT - US03969K1088 - Common Stock
24.21 USD
-0.17 (-0.7%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.69M | 59.606M 1,515.34% | 196.542M 229.74% | 364.14M 85.27% | 475.92M 30.70% | 621.32M 30.55% | 777.7M 25.17% | 916.95M 17.91% | 1.057B 15.27% | 1.143B 8.14% | 1.245B 8.92% | |
| EBITDA YoY % growth | -300.7M -45.91% | -239.58M 20.33% | -125.798M 47.49% | -35.601M 71.70% | 13.078M 136.74% | 84.811M 548.50% | 232.76M 174.45% | 321.5M 38.13% | 400.76M 24.65% | 494.8M 23.47% | N/A | |
| EBIT YoY % growth | -301.63M -46.05% | -241.101M 20.07% | -128.397M 46.75% | -55.132M 57.06% | 26.087M 147.32% | 164.47M 530.47% | 311.8M 89.58% | 435.83M 39.78% | 550.66M 26.35% | 618.79M 12.37% | 712.2M 15.10% | |
| Operating Margin | -8,174.25% | -404.49% | -65.33% | -15.14% | 5.48% | 26.47% | 40.09% | 47.53% | 52.10% | 54.14% | 57.20% | |
| EPS YoY % growth | -5.65 -35.82% | -3.92 30.62% | -1.16 70.41% | -0.21 82.00% | 0.37 277.67% | 1.23 232.50% | 2.31 87.21% | 3.04 31.80% | 3.39 11.33% | 3.66 7.99% | 4.02 9.97% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.06 166.87% | -0.01 94.90% | 0.01 110.46% | 0.09 44.50% | 0.13 120.34% |
| Revenue Q2Q % growth | 111.98M 56.92% | 97.617M 48.25% | 108M 32.51% | 118.32M 19.25% | 133.11M 18.87% |
| EBITDA Q2Q % growth | 24.569M 588.16% | 16.848M 178.74% | N/A | N/A | N/A |
| EBIT Q2Q % growth | 4.118M 153.96% | -1.377M 94.39% | 7.038M 148.17% | 13.311M 56.12% | 21.777M 428.82% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.06 118.18% | -0.10 | 0.16 | 157.48% |
| Q2 2025 Q2Q % growth | -0.13 69.05% | -0.16 | 0.03 | 19.41% |
| Q1 2025 Q2Q % growth | -0.20 37.50% | -0.21 | 0.01 | 6.63% |
| Q4 2024 Q2Q % growth | -0.09 87.50% | -0.26 | 0.17 | 65.40% |
| Q3 2024 Q2Q % growth | -0.33 54.79% | -0.43 | 0.10 | 22.44% |
| Q2 2024 Q2Q % growth | -0.42 63.79% | -0.53 | 0.11 | 20.28% |
| Q1 2024 Q2Q % growth | -0.32 75.57% | -0.74 | 0.42 | 57.02% |
| Q4 2023 Q2Q % growth | -0.72 38.98% | -0.79 | 0.07 | 8.92% |
| Q3 2023 Q2Q % growth | -0.73 61.38% | -0.87 | 0.14 | 16.54% |
| Q2 2023 Q2Q % growth | -1.16 11.45% | -1.28 | 0.12 | 9.03% |
| Q1 2023 Q2Q % growth | -1.31 -3.15% | -1.31 | 0.00 | 0.03% |
| Q4 2022 Q2Q % growth | -1.18 16.90% | -1.45 | 0.27 | 18.71% |
| Q3 2022 Q2Q % growth | -1.89 -65.79% | -1.70 | -0.19 | -11.03% |
| Q2 2022 Q2Q % growth | -1.31 -55.95% | -1.46 | 0.15 | 10.40% |
| Q1 2022 Q2Q % growth | -1.27 -67.11% | -1.53 | 0.26 | 17.10% |
| Q4 2021 Q2Q % growth | -1.42 -79.75% | -1.52 | 0.10 | 6.88% |
| Q3 2021 Q2Q % growth | -1.14 -12.87% | -1.17 | 0.03 | 2.95% |
| Q2 2021 Q2Q % growth | -0.84 10.64% | -0.92 | 0.08 | 8.67% |
| Q1 2021 Q2Q % growth | -0.76 33.91% | -0.98 | 0.22 | 22.18% |
| Q4 2020 Q2Q % growth | -0.79 87.22% | -0.90 | 0.11 | 11.99% |
| Q3 2020 Q2Q % growth | -1.01 | -0.92 | -0.09 | -9.72% |
| Q2 2020 Q2Q % growth | -0.94 | -0.86 | -0.08 | -9.28% |
| Q1 2020 Q2Q % growth | -1.15 | -0.94 | -0.21 | -22.99% |
| Q4 2019 Q2Q % growth | -6.18 | -9.39 | 3.21 | 34.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 99.219M 121.69% | 88.718M | 10.501M | 11.84% |
| Q2 2025 Q2Q % growth | 81.504M 164.13% | 75.162M | 6.342M | 8.44% |
| Q1 2025 Q2Q % growth | 65.846M 32.84% | 63.495M | 2.351M | 3.70% |
| Q4 2024 Q2Q % growth | 71.36M 427.58% | 61.363M | 9.997M | 16.29% |
| Q3 2024 Q2Q % growth | 44.755M 17.44% | 38.369M | 6.386M | 16.64% |
| Q2 2024 Q2Q % growth | 30.858M 494.57% | 29.662M | 1.196M | 4.03% |
| Q1 2024 Q2Q % growth | 49.569M 1,682.42% | 14.974M | 34.595M | 231.03% |
| Q4 2023 Q2Q % growth | 13.526M 356.96% | 11.567M | 1.959M | 16.94% |
| Q3 2023 Q2Q % growth | 38.109M 5,120.41% | 33.485M | 4.624M | 13.81% |
| Q2 2023 Q2Q % growth | 5.19M | 4.692M | 498K | 10.61% |
| Q1 2023 Q2Q % growth | 2.781M | 3.2M | -419K | -13.09% |
| Q4 2022 Q2Q % growth | 2.96M | 2.247M | 713K | 31.73% |
| Q3 2022 Q2Q % growth | 730K | 663K | 67K | 10.11% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.75% | 11.68% | 2.73% | 19.45% |
| Revenue | 0.55% | 7.3% | 0.53% | 7.13% |